[go: up one dir, main page]

MX2018015965A - Composicion de dos componentes. - Google Patents

Composicion de dos componentes.

Info

Publication number
MX2018015965A
MX2018015965A MX2018015965A MX2018015965A MX2018015965A MX 2018015965 A MX2018015965 A MX 2018015965A MX 2018015965 A MX2018015965 A MX 2018015965A MX 2018015965 A MX2018015965 A MX 2018015965A MX 2018015965 A MX2018015965 A MX 2018015965A
Authority
MX
Mexico
Prior art keywords
component composition
asa
new
providing
oral administration
Prior art date
Application number
MX2018015965A
Other languages
English (en)
Other versions
MX388400B (es
Inventor
Bjorn Fredrikson John
Original Assignee
Asamedic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asamedic As filed Critical Asamedic As
Publication of MX2018015965A publication Critical patent/MX2018015965A/es
Publication of MX388400B publication Critical patent/MX388400B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/072—Sealing capsules, e.g. rendering them tamper-proof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una nueva composición de dos componentes que comprende ácido acetilsalicílico (ASA) y que es particularmente útil para proporcionar una solución acuosa de ASA para administración oral inmediata.
MX2018015965A 2016-06-28 2017-06-28 Una composición de dos componentes, que comprende ácido acetilsalicílico. MX388400B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20161073 2016-06-28
PCT/EP2017/065970 WO2018002124A1 (en) 2016-06-28 2017-06-28 Two-component composition

Publications (2)

Publication Number Publication Date
MX2018015965A true MX2018015965A (es) 2019-05-22
MX388400B MX388400B (es) 2025-03-20

Family

ID=59285173

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015965A MX388400B (es) 2016-06-28 2017-06-28 Una composición de dos componentes, que comprende ácido acetilsalicílico.

Country Status (25)

Country Link
US (3) US11918554B2 (es)
EP (2) EP3871677A1 (es)
JP (2) JP2019520377A (es)
KR (1) KR102397334B1 (es)
CN (2) CN109789152A (es)
AU (1) AU2017288465B2 (es)
BR (1) BR112018076553A2 (es)
CA (1) CA3027462A1 (es)
CY (1) CY1124724T1 (es)
DK (1) DK3474858T3 (es)
EA (1) EA201990093A1 (es)
ES (1) ES2897981T3 (es)
HR (1) HRP20211761T1 (es)
HU (1) HUE056659T2 (es)
IL (1) IL263982B (es)
LT (1) LT3474858T (es)
MX (1) MX388400B (es)
MY (1) MY195384A (es)
NZ (1) NZ749230A (es)
PL (1) PL3474858T3 (es)
PT (1) PT3474858T (es)
RS (1) RS62574B1 (es)
SI (1) SI3474858T1 (es)
SM (1) SMT202100645T1 (es)
WO (1) WO2018002124A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056659T2 (hu) 2016-06-28 2022-03-28 Asamedic As Kétkomponensû, acetilszalicilsavat tartalmazó készítmény
EP3501523A1 (en) * 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
WO2020150460A1 (en) * 2019-01-18 2020-07-23 Milne Iii Donald A Micronized aspirin formulation

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912894A (en) * 1959-11-02 1962-12-12 Guy Leopold Van Moorleghem Method for the preparing a solution of aspirin for injection and product obtained thereby
AT222276B (de) * 1959-11-02 1962-07-10 Guy Leopold Van Moorleghem Verfahren zur Herstellung einer injizierbaren Lösung von Acetylsalicylsäure
FR304M (fr) * 1960-08-19 1961-03-20 Guy Soluté injectable d'aspirine et son procédé de fabrication.
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
AU632602B2 (en) * 1989-08-02 1993-01-07 John David Arnold Method and preparation for reducing risk of myocardial infarction
US5157030A (en) * 1989-08-25 1992-10-20 Alexander Galat Rapidly soluble aspirin compositions and method
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
JPH07157432A (ja) * 1993-12-07 1995-06-20 Daikyo Yakuhin Kogyo Kk 貼付剤
GB9701160D0 (en) 1997-01-21 1997-03-12 Parkinson Sidney Medicament dispenser
IT1292677B1 (it) 1997-02-28 1999-02-11 Bormioli Metalplast Spa Confezione per mantenere separati dei prodotti prima dell'uso.
US5776431A (en) 1997-03-26 1998-07-07 Galat; Alexander Water-soluble aspirin composition
JP4126405B2 (ja) 1998-02-02 2008-07-30 甲陽ケミカル株式会社 芳香族カルボン酸類の溶解度向上化水溶液
NO309761B1 (no) 1999-05-03 2001-03-26 Anders Aelveborn Beholder eller kapsel for adskilt oppbevaring av to- komponents blandbare materialer
GB0018322D0 (en) 2000-07-27 2000-09-13 Boots Co Plc Pharmaceutical compositions
US7029701B2 (en) 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1525765A1 (en) 2002-06-25 2005-04-27 Nokia Corporation Routing method and network element
ITMI20022619A1 (it) * 2002-12-11 2004-06-12 Ind Italiana Integratori Trei S P A Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
CN1418635A (zh) 2002-12-19 2003-05-21 王登之 治疗感冒发热的阿司匹林口腔崩解片及其制备方法
EP1621200A1 (en) 2004-07-26 2006-02-01 Fournier Laboratories Ireland Limited Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
US7598233B2 (en) 2005-03-28 2009-10-06 Kowa Co., Ltd. Method for treating thrombosis
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production
US20070092561A1 (en) * 2005-06-24 2007-04-26 Don Milne Water-Soluble Aspirin Composition
US7614496B2 (en) 2005-08-29 2009-11-10 Steven Dvorak Aqueous solution of an analgesic and a dispenser therefor
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
CN101632647A (zh) 2008-07-21 2010-01-27 北京迈劲医药科技有限公司 阿司匹林与碱性药物组成的复方制剂的制备方法
US20100125242A1 (en) 2008-11-15 2010-05-20 Pharmstar Pharmaceuticals, Inc. Emergency dose medication administration device
CA3213470A1 (en) * 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
US8173625B2 (en) 2009-05-08 2012-05-08 Theaprin Pharmaceuticals Inc. Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
US8580853B2 (en) 2011-06-13 2013-11-12 Howard PHYKITT Analgesic composition and method of making the same
EP2900269B1 (en) * 2012-09-25 2018-08-01 Bayer Pharma Aktiengesellschaft Combination of regorafenib and acetylsalicylic acid for treating colorectal cancer
PL3060203T3 (pl) 2013-10-23 2018-01-31 Bayer Healthcare Llc Tabletka musująca zawierająca wysoki poziom aspiryny
EP2777802B1 (en) 2013-12-03 2016-03-16 Capsugel Belgium NV Multi-compartment dosage form articles
WO2017001468A1 (en) 2015-07-02 2017-01-05 Asamedic As Two-component composition
HUE056659T2 (hu) 2016-06-28 2022-03-28 Asamedic As Kétkomponensû, acetilszalicilsavat tartalmazó készítmény
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt

Also Published As

Publication number Publication date
IL263982A (en) 2019-01-31
CY1124724T1 (el) 2022-07-22
RS62574B1 (sr) 2021-12-31
BR112018076553A2 (pt) 2019-04-02
US20210212976A1 (en) 2021-07-15
CN117982446A (zh) 2024-05-07
MX388400B (es) 2025-03-20
US20220218724A1 (en) 2022-07-14
KR102397334B1 (ko) 2022-05-11
ES2897981T3 (es) 2022-03-03
PL3474858T3 (pl) 2022-01-17
HRP20211761T1 (hr) 2022-02-18
AU2017288465B2 (en) 2019-10-10
MY195384A (en) 2023-01-18
CN109789152A (zh) 2019-05-21
JP2019520377A (ja) 2019-07-18
EP3871677A1 (en) 2021-09-01
LT3474858T (lt) 2021-12-27
WO2018002124A1 (en) 2018-01-04
US11369581B2 (en) 2022-06-28
JP2023027071A (ja) 2023-03-01
CA3027462A1 (en) 2018-01-04
US11918554B2 (en) 2024-03-05
EP3474858A1 (en) 2019-05-01
SI3474858T1 (sl) 2022-01-31
JP7520941B2 (ja) 2024-07-23
EA201990093A1 (ru) 2019-07-31
IL263982B (en) 2022-03-01
DK3474858T3 (da) 2021-11-22
US20240216318A1 (en) 2024-07-04
KR20190040184A (ko) 2019-04-17
HUE056659T2 (hu) 2022-03-28
PT3474858T (pt) 2021-11-22
AU2017288465A1 (en) 2019-01-17
EP3474858B1 (en) 2021-08-18
NZ749230A (en) 2023-05-26
SMT202100645T1 (it) 2022-01-10

Similar Documents

Publication Publication Date Title
CY1122951T1 (el) Φαρμακευτικα σκευασματα ενος αναστολεα υδροξυλασης ηιf
CU20170172A7 (es) 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos
CL2016002517A1 (es) Uso de ácido r-2-4-2-etoxi-3-4-trifluormetilfenoxipropil-tio-2-metilfenoxi acético o una sal del mismo en la fabricación de un medicamento para tratar una condición que es una enfermedad de hígado graso no alcohólico o esteatohepatitis no alcohólica.
SV2018005643A (es) Composiciones de insulina de rapida accion
AR098168A1 (es) Formulación estable de insulina glulisina
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
MX343035B (es) Formulacion farmaceutica novedosa que comprende nsaid y ciclodextrina.
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
CY1124724T1 (el) Συνθεση δυο συστατικων που περιλαμβανει ακετυλοσαλικυλικο οξυ
BR112015025852A2 (pt) as formulações de oxabicicloheptanos e oxabicicloheptenos
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
CO6650346A2 (es) Composiciones de tetraciclina
CL2017000715A1 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
CL2015002253A1 (es) Composiciones farmacéuticas para el tratamiento de la helicobacter pylori.
PE20180039A1 (es) Piroglutamato de vortioxetina
CL2017000230A1 (es) Composición adhesiva
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
ES2722926T3 (es) Combinación de levocabastina y furoato de fluticasona para el tratamiento de condiciones inflamatorias y/o alérgicas
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
ECSP15050273A (es) Formulación oral para el tratamiento de enfermedades cardiovasculares
UY35690A (es) Composiciones farmacéuticas de ranolazina y dronedarona
CL2017001077A1 (es) Composiciones farmacéuticas que comprenden lobeglitazona para administración oral
BR112017006613A2 (pt) composição herbicida e processo da mesma
CL2020001705A1 (es) Composición acuosa que comprende ácido 2-(dimetil-1h-pirazol-1-il) succínico y amoníaco.